Maxcyte, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
MXCT on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
9713 Key West Avenue,, Suite 400, Rockville, MD

Insiders trading volume in the past year

Maxcyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Casdin Partners Master Fund, L.P. 10%+ Owner $45.3M Oct 3, 2022
Art Mandell Director $1.94M Jun 11, 2024
Douglas Doerfler President and CEO, Director $1.51M Dec 4, 2023
Stanley C. Erck Director $547K +$137K +33.5% Aug 13, 2025
J. Stark Thompson Phd Director $502K Aug 9, 2021
John Joseph Johnston Director $377K -$35.4K -8.6% Jun 18, 2025
Douglas Richard Director $320K +$111K +53.1% Aug 13, 2025
Maher Masoud President and CEO, Director $240K +$103K +75% Aug 13, 2025
Douglas J. Swirsky Chief Financial Officer $209K +$42.4K +25.5% Aug 13, 2025
David Sandoval General Counsel $204K -$21.4K -9.48% Mar 18, 2025
William W. Brooke Director $195K +$64.5K +49.6% Aug 13, 2025
Ali Soleymannezhad Chief Commercial Officer $189K -$3.85K -2% Mar 18, 2025
Cynthia Collins Director $178K Jun 18, 2025
Yasir B. Al-Wakeel Director $111K Jun 18, 2025
Patrick J. Balthrop Director $111K Jun 18, 2025
Thomas M. Ross Evp, Global Sales $109K Aug 1, 2024
Rekha Hemrajani Director $83.6K -$22.4K -21.1% Jun 25, 2025
Cenk Sumen Chief Scientific Officer Apr 11, 2022
Amanda Louise Murphy Chief Financial Officer Mar 25, 2022
Ron Holtz Chief Financial Officer Mar 20, 2023

Recent Insider Transactions by Companies or Individuals for Maxcyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.